Moore Capital Management
MYOK

Moore Capital Management’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Moore Capital Management’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-64,393
Closed -$3.36M – 390
2019
Q3 		$3.36M Buy
64,393
+4,109
+7% +$219K 0.13% 176
2019
Q2 		$3.02M Buy
60,284
+41,084
+214% +$2M 0.07% 209
2019
Q1 		$998K Buy
+19,200
New +$885K 0.03% 238
2016
Q4 		– Sell
-50,000
Closed -$817K – 309
2016
Q3 		$817K Buy
+50,000
New +$903K 0.03% 159

Other funds holding MYOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Farallon Capital Management
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Avoro Capital Advisors
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Bellevue Group
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Perceptive Advisors
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Moore Capital Management's MYOK Position: Q4 2019 in Review

Moore Capital Management sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2019, closing a stake of 64,393 shares — an estimated $3.36M sold.

Moore Capital Management first reported a position in MYOK in Q3 2016 and held it in 4 quarters. The position peaked at $3.36M in Q3 2019. 178 funds tracked by Wall St. Rank hold MYOK as of Q4 2019.

  • Moore Capital Management reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Moore Capital Management sold 64,393 MyoKardia, Inc. Common Stock shares in Q4 2019, an estimated $3.36M.
  • Moore Capital Management first reported a position in MyoKardia, Inc. Common Stock in Q3 2016 and held it in 4 quarters.
  • Moore Capital Management's MyoKardia, Inc. Common Stock position peaked at $3.36M in Q3 2019.
  • 178 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2019.

Based on Moore Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.